Therefore, modulation of TRPA1 functions might become a target for prevention or therapy of carboplatin-induced CIPN, which could improve chemotherapy with carboplatin to improve their quality of life and prognosis of cancer patients. This evidence concerns the gene TRPA1 and cancer.